These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6941443)

  • 1. Nitroimidazoles and anaerobic infections. A symposium held in Norrtälje, Sweden, March 21-22, 1980.
    Scand J Infect Dis Suppl; 1981; 26():1-141. PubMed ID: 6941443
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaerobic infections: the role of tinidazole. Proceedings of a symposium: Edinburgh, Scotland, 19 and 20 April 1982.
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():1-187. PubMed ID: 7118766
    [No Abstract]   [Full Text] [Related]  

  • 3. [The 5-nitroimidazoles].
    Gerson C
    Soins; 1993 Nov; (578):59-60. PubMed ID: 8140475
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of ornidazole in the management of anaerobic bacterial infections].
    Durocher A; Wattel F
    Lille Med; 1981 Mar; 26(3):146-8. PubMed ID: 7289752
    [No Abstract]   [Full Text] [Related]  

  • 6. Tinidazole v. metronidazole.
    Drug Ther Bull; 1983 Nov; 21(23):90-2. PubMed ID: 6641520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment using nitroimidazoles in orofacial infections].
    von Konow L
    Tandlakartidningen; 1984 Mar; 76(5):264-7. PubMed ID: 6588629
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postoperative meningitis due to multiple aerobic and anaerobic organisms treated with ornidazole (author's transl)].
    Thyss J; Chabert JM; Bocquet JP; Gazaix M; Korn M; Carles D; Etesse H
    Nouv Presse Med; 1980 Feb; 9(6):381. PubMed ID: 7383909
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of anaerobic infections].
    Eijsten A; Lüthy R
    Schweiz Med Wochenschr; 1980 Oct; 110(43):1563-6. PubMed ID: 7466332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections.
    Goldman P
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():23-33. PubMed ID: 6749793
    [No Abstract]   [Full Text] [Related]  

  • 11. Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system.
    Jokipii AM; Jokipii L
    Scand J Infect Dis Suppl; 1981; 26():123-9. PubMed ID: 6941449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance in anaerobic bacteria. Based on a symposium held at the 12th International Congress of Chemotherapy Florence, 22 July 1981.
    J Antimicrob Chemother; 1981 Dec; 8 Suppl D():1-132. PubMed ID: 7338484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Single dose of tinidazole in prevention of post-hysterectomy infections].
    Karhunen M; Koskela O; Hannelin M
    Duodecim; 1980; 96(17):1135-8. PubMed ID: 7249949
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of the North American Metronidazole Symposium. Anaerobic infections. Scottsdale, Arizona, October 7-9, 1981.
    Surgery; 1983 Jan; 93(1 Pt 2):123-234. PubMed ID: 6849196
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nitroimidazole trichomonacidal preparations in the treatment of anaerobic pelvic infections].
    Presl J
    Cesk Gynekol; 1983 Mar; 48(2):133-4. PubMed ID: 6850883
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis and treatment of anaerobic infections. A symposium held in Bergen, Norway, June 21, 1984.
    Scand J Infect Dis Suppl; 1985; 46():1-114. PubMed ID: 3865347
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic use of ornidazole in digestive surgery in neonates and children].
    Vigier C; Vigier JE; Vermersch S; Debeugny P; Krivosic-Horber R
    LARC Med; 1982 Mar; 2(3):260-3. PubMed ID: 7169917
    [No Abstract]   [Full Text] [Related]  

  • 18. The versatility of nitro compounds.
    Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1976 Mar; 2(1):5-8. PubMed ID: 931834
    [No Abstract]   [Full Text] [Related]  

  • 19. Reductive activation of nitroheterocyclic compounds.
    Tocher JH
    Gen Pharmacol; 1997 Apr; 28(4):485-7. PubMed ID: 9147012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotetan, a new approach in the management of mixed infections. Cambridge symposium. March 30, 1988. Abstracts.
    Acta Chir Belg; 1988; Suppl 6():1-26. PubMed ID: 3227744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.